Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1768 of 6351
-
Brain zaps boost OCD therapy in youth trial
Symptom relief Recruiting nowThe goal of this clinical trial is to compare different forms of transcranial magnetic stimulation (TMS) for improving the outcomes of Exposure with Response Prevention (ERP) in youth and young adults with Obsessive-Compulsive Disorder (OCD). Researchers will compare three groups…
Sponsor: Bradley Hospital • Aim: Symptom relief
Last updated Aug 23, 2026 00:00 UTC
-
New drug switch may control lung cancer longer in High-Risk patients
Disease control Stopped earlyIn this study, the researchers will look at whether having participants switch from durvalumab to sotorasib when they have detectable minimal residual disease (MRD) is an effective treatment approach for locally advanced non-small cell lung cancer (LA-NSCLC). The researchers will…
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
VR headset could help treat OCD symptoms
Symptom relief Recruiting nowThe aim of this study is to evaluate the efficacy of virtual reality exposure therapy (VRET) as a treatment for obsessive-compulsive disorder (OCD). This study focuses on patients receiving treatment in outpatient psychiatry or clinical psychology settings, utilizing a within-sub…
Sponsor: National Institute of Mental Health, Czech Republic • Aim: Symptom relief
Last updated Jun 27, 2026 07:53 UTC
-
Zapping the vagus nerve during meditation may help fight alcohol cravings
Disease control Recruiting nowOur primary objective is to integrate tVNS and mindfulness meditation within a structured mindfulness-based relapse prevention (MBRP) program for detoxified alcohol-dependent patients (AD). We aim to determine whether neuromodulation can enhance mindfulness-based relapse preventi…
Sponsor: Charite University, Berlin, Germany • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Can the shingles vaccine protect transplant patients? new study aims to find out
Vaccine Recruiting nowThe goal of this clinical trial is to compare responses to Varicella Zoster vaccination between transplant patients on different medication regimens, and their healthy co-habitants. The main questions it aims to answer are: 1. Are there differences in vaccination immunological r…
Sponsor: Central Adelaide Local Health Network Incorporated • Aim: Vaccine
Last updated Jun 27, 2026 12:05 UTC
-
Higher defibrotide doses may help severe transplant complication
Disease control Recruiting nowThis research study is being done to determine the safety and tolerability of increasing doses of defibrotide within a single patient with sinusoidal obstructive syndrome (SOS)/veno-occlusive disease (VOD) after hematopoietic cell transplantation (HCT) associated with either kidn…
Phase 2 • Sponsor: New York Medical College • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Can a gentle electric current ease the pain of braces?
Symptom relief CompletedOrthodontic treatment often causes pain during the initial alignment stage which can lead to discomfort, reduced compliance, and slower treatment progress. Potential Solution: Transcutaneous Electrical Nerve Stimulation (TENS) is a non-invasive, non-pharmacological approach that…
Sponsor: Foundation University Islamabad • Aim: Symptom relief
Last updated Aug 14, 2026 00:00 UTC
-
Which bile duct stone removal method is safer? a large swedish study investigates
Disease control CompletedLaparoscopic endobiliary stent and postponed endoscopic retrograde cholangiopancreatography, ERCP, compared to intraoperative ERCP for the treatment of common bile duct stones, CBDS, a retrospective registry based cohort study. Data will be collected from GallRiks, the Swedish n…
Sponsor: Karolinska Institutet • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Which anesthesia is safer for frail hip fracture patients?
Disease control CompletedThe goal of this observational study is to compare the regional anesthetic methods (not including general anesthesia) -spinal anesthesia, erector spinae plane (ESP) block- which are in routine practice in critically ill adult patients operated for femur fracture, in terms of intr…
Sponsor: Duzce University • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
New meningitis vaccine shows promise for infants in major trial
Vaccine CompletedThis study is conducted to support a 2-dose series (1+1 vaccination schedule) for immunization of individuals from 6 months of age. The study is designed to evaluate the non-inferiority of the immunological response of MenACYW conjugate vaccine to Nimenrix® after the completion o…
Phase 3 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: Vaccine
Last updated Jun 27, 2026 08:01 UTC
-
Virtual diet program aims to stop obesity in young leukemia patients
Prevention Recruiting nowThe purpose of this study is determine the effectiveness of a six-month virtually-delivered dietary education intervention (PEDALL) on the prevention of overweight and obesity (OW/OB) during maintenance chemotherapy in children and adolescents with acute lymphoblastic leukemia (A…
Sponsor: Columbia University • Aim: Prevention
Last updated Jun 27, 2026 07:53 UTC
-
Your voice may reveal hidden depression: new study tests speech screening
Diagnosis CompletedMajor depressive disorder (MDD) and anxiety are increasingly prevalent among university student populations, yet early detection remains reliant on psychometric instruments tied to diagnostic criteria (e.g., PHQ-9, GAD). Emerging evidence suggests that depression affects both the…
Sponsor: Accexible • Aim: Diagnosis
Last updated Jun 27, 2026 12:31 UTC
-
Glow-in-the-Dark dye could prevent surgical accidents
Symptom relief CompletedThe ureter is the tube that carries urine from the kidneys to the bladder. It is difficult for surgeons to see the ureter during abdominal surgery. This could lead to injuring the ureter which, although rare, could be serious. This study is about a potential new medical dye, cal…
Phase 3 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC
-
New experimental drug CTX-8371 enters first human tests for tough cancers
Disease control Recruiting nowThis is a Phase 1, open-label, first-in-human study of CTX-8371 administered as a monotherapy in patients with metastatic or locally advanced malignancies. The study will be conducted in 2 cohorts: Dose Escalation and Dose Expansion.
Phase 1 • Sponsor: Compass Therapeutics • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Standing within hours of spine surgery: a new test for teen recovery
Symptom relief CompletedThe implementation of an enhanced rehabilitation after surgery (ERAS) program in major orthopedic surgery and in scoliosis surgery in children and adolescents has become a marker of good practice. Investigators are already applying anesthetic, surgical, peri-operative medicine an…
Sponsor: University Hospital, Toulouse • Aim: Symptom relief
Last updated Aug 15, 2026 00:00 UTC
-
New drug aims to quiet MS brain lesions
Disease control OngoingThe main purpose of this study is to evaluate the safety and efficacy of LY3541860 in adult participants with multiple sclerosis that gets worse and gets better. The study will last about 9 months with additional 6 months follow-up.
Phase 2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Van clinic delivers lifesaving prevention to women at high risk
Prevention CompletedThe investigators will implement a non-randomized observational clinical trial that will include a pop-up clinic for women who inject drugs (WWID) near venues for exchange sex and drug use in north Seattle. The pop-up clinic will be housed within a van and serve as a research ext…
Sponsor: University of Washington • Aim: Prevention
Last updated Jun 27, 2026 09:07 UTC
-
Gout drug study aims for fewer infusions, same relief
Disease control CompletedThe study consists of 24-week double-blind trial to evaluate the non-inferiority of the efficacy and safety of pegloticase Q4W with MTX versus pegloticase Q2W with MTX, followed by a 24-week open-label extension of pegloticase Q4W with MTX, in participants with uncontrolled refra…
Phase 4 • Sponsor: Amgen • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New weekly shot shows promise for diabetes and weight loss
Disease control CompletedThis study will look at how well a new medicine called NNC0519-0130 helps people with type 2 diabetes lower their blood sugar and body weight. The study will test up to 7 different doses of NNC0519-0130. Which treatment participant will get is decided by chance. Participants will…
Phase 2 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Walking your way to better health: smartphone program shows promise for heart and diabetes patients
Disease control CompletedThis study evaluated whether a three-month smartphone-supported daily walking intervention could improve physical activity, psychological well-being, and body composition in adults with cardiometabolic disease. Participants had cardiovascular disease and/or type 2 diabetes and us…
Sponsor: Klaipėda University • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC